Detalhe da pesquisa
1.
COVID-19 outcomes in a large pediatric hematology-oncology center in Houston, Texas.
Pediatr Hematol Oncol
; 38(8): 695-706, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34032552
2.
A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma.
Pediatr Blood Cancer
; 67(6): e28283, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32285998
3.
Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411).
Pediatr Blood Cancer
; 67(2): e28073, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31724813
4.
Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1-2 trial.
Lancet Oncol
; 19(9): 1229-1238, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30122620
5.
Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 65(3)2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29090524
6.
A pediatric brain tumor consortium phase II trial of capecitabine rapidly disintegrating tablets with concomitant radiation therapy in children with newly diagnosed diffuse intrinsic pontine gliomas.
Pediatr Blood Cancer
; 65(2)2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29090526
7.
A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314).
Pediatr Blood Cancer
; 65(8): e27066, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29719113
8.
A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114).
Br J Haematol
; 177(3): 467-474, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28295182
9.
A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111).
Pediatr Blood Cancer
; 64(11)2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28449393
10.
Phase 2 trial of sorafenib in children and young adults with refractory solid tumors: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 62(9): 1562-6, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26207356
11.
Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 62(3): 440-4, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25446280
12.
Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group.
Pediatr Blood Cancer
; 62(5): 743-50, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25307519
13.
Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium.
Pediatr Blood Cancer
; 62(1): 45-51, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25257751
14.
A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011).
Pediatr Blood Cancer
; 62(10): 1717-24, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25976292
15.
A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium report.
Pediatr Blood Cancer
; 62(5): 751-8, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25728527
16.
Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study.
Childs Nerv Syst
; 31(8): 1283-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25930724
17.
Editorial: Recent advances in pediatric oncology.
Curr Opin Pediatr
; 31(1): 1-2, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30614919
18.
Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 61(3): 452-6, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23956055
19.
A phase I trial of MK-2206 in children with refractory malignancies: a Children's Oncology Group study.
Pediatr Blood Cancer
; 61(7): 1246-51, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24664955
20.
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.
Pediatr Blood Cancer
; 61(9): 1598-602, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24753394